Back to results
US 2020/0270241 A1Published application
Esters of dihydrotetrabenazine
AssigneeForesee Pharmaceuticals Co., Ltd.
InventorsYuhua LI, Chen-Chang LEE, Wen-Yen HUANG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula (I) including any stereochemically isomeric form thereof, or a pharmaceutically acceptable salt thereof. wherein R1 is —C(═O)O-alkyl, carbonate ester, or —C(═O)-alkyl, ester, or —C(═O)N-alkyl, carbamate ester and wherein R2 is —CH3 or —CD3. The alkyl ester can contain saturated or unsaturated C12 to C26 alkyl carbon. The alkyl carbon chain can have either a straight, branched, noncyclic, cyclic, unsubstituted or substituted structure.
Claims15
A compound of formula (I)
- including (+)-α-DHTBZ and (+)-I3-DHTBZ isomeric form thereof or a pharmaceutically acceptable salt thereof;
- wherein R1 is a saturated or unsaturated alkyl derivatives containing from 12 to 26 carbon atom having a straight, branched, noncyclic, cyclic or unsubstituted or substituted structure, and R2 is —CH3 or —CD3.
Dependencies are inferred from the claim text.